Yttrium chloride Y-90

Yttrium chloride Y-90 is used in targeted radiotherapy for liver tumors, especially in hepatocellular carcinoma (HCC) and liver metastases from colorectal cancer and neuroendocrine tumors (NETs), via a procedure called radioembolization (RE) or selective internal radiation therapy (SIRT). Y-90 microspheres are delivered to tumors via the hepatic artery, where the high-energy beta particles from Y-90 destroy the tumor cells with minimal damage to surrounding healthy liver tissue. It can be used as a standalone treatment, in combination with systemic chemotherapy, or to downstage tumors for other procedures like transplantation. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Ytracis and Yttriga. Its PubChem CID is 71586740.

CAS No 39271-65-3
Molecular Formula Cl3Y
Molecular Weight 196.26 g/mol
Synonyms trichloro(90Y)yttrium-90

Frequently Asked Questions